Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knoll

Showing results (21-30 of 390) with videos related to

Pageof 39
Sort By:
Pharmacology & Toxicology|August 1, 1994
Memories of my 45 years in researchJ Knoll
Pharmacology & Toxicology|May 1, 1992
The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal viewJ Knoll
Orvosi Hetilap|September 26, 1976
[Academician Béla Issekutz 90 years old]J Knoll
Annual Review of Pharmacology and Toxicology|January 1, 1988
Endogenous anorectic agents--satietinsJ Knoll
Advances in Neurology|January 1, 1990
Nigrostriatal dopaminergic activity, deprenyl treatment, and longevityJ Knoll
Orvosi Hetilap|November 11, 1979
[Béla Issekutz (1886-1979)]J Knoll
Journal of Neural Transmission. Supplementum|January 1, 1987
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuronJ Knoll
Progress in Clinical and Biological Research|January 1, 1985
Satietin, a blood-borne glycoprotein in the regulation of food intakeJ Knoll
Journal of the American Geriatrics Society|August 1, 1992
(-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic systemJ Knoll
Neuropharmacology|December 1, 1975
Predictive values of pharmacological models to study opiate dependenceJ Knoll
Pageof 39

Showing results (21-30 of 390) with videos related to

Sort By:
Pageof 39
Pharmacology & Toxicology|August 1, 1994
Memories of my 45 years in researchJ Knoll
Pharmacology & Toxicology|May 1, 1992
The pharmacological profile of (-)deprenyl (selegiline) and its relevance for humans: a personal viewJ Knoll
Orvosi Hetilap|September 26, 1976
[Academician Béla Issekutz 90 years old]J Knoll
Annual Review of Pharmacology and Toxicology|January 1, 1988
Endogenous anorectic agents--satietinsJ Knoll
Advances in Neurology|January 1, 1990
Nigrostriatal dopaminergic activity, deprenyl treatment, and longevityJ Knoll
Orvosi Hetilap|November 11, 1979
[Béla Issekutz (1886-1979)]J Knoll
Journal of Neural Transmission. Supplementum|January 1, 1987
R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuronJ Knoll
Progress in Clinical and Biological Research|January 1, 1985
Satietin, a blood-borne glycoprotein in the regulation of food intakeJ Knoll
Journal of the American Geriatrics Society|August 1, 1992
(-)Deprenyl-medication: a strategy to modulate the age-related decline of the striatal dopaminergic systemJ Knoll
Neuropharmacology|December 1, 1975
Predictive values of pharmacological models to study opiate dependenceJ Knoll
Pageof 39